If persistent, consider reducing dose
GLP-1 medications work through several complementary mechanisms: Enhancing insulin secretion from pancreatic beta cells in a glucose-dependent manner, which helps lower blood sugar levels Suppressing glucagon release , thereby reducing hepatic glucose production Slowing gastric emptying , which prolongs satiety and reduces appetite Acting on appetite centres in the brain , leading to reduced caloric intake and weight loss Commonly prescribed GLP-1 receptor agonists available in the UK include semaglutide (Ozempic, Wegovy, Rybelsus [oral form]), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and exenatide (Byetta, Bydureon)
Are GLP-1 medications available as a pill
GLP-1s are then identified as those classified under A10BJ or glucagon-like peptide-1 (GLP-1) analogues
Several factors influence the rate of absorption from a subcutaneous site: Blood Flow: The local blood flow to the adipose tissue can affect how quickly the compound is carried away